Striae GravidarumEM/SGNCT07265440
Effect of New Specialized Technique Using Effleurage Massage on Striae Gravidarum
A study testing New specialized technique using effleurage massage in people with Striae Gravidarum, run by Kafrelsheikh University at 1 site in Egypt.
Trial summary
The goal of this clinical trial is to learn if our new specialized technique using effleurage massage works to prevent striae gravidarum in primigravida. The main questions it aims to answer are: Can our new specialized technique using effleurage massage prevent or even decrease the severity of striae gravidarum in… Read more about this study
- Who is it for?
- Ages 20 to 30 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Striae Gravidarum
- What is being tested?
- New specialized technique using effleurage massage
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 42 participants
- Where
- 1 siteEgypt
- Study dates
- 9 Oct 2024to 30 May 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 30 years
- Women only
- Healthy volunteers accepted
- Adult
Who may be able to join
- • All females will be primigravida.
- All females will be at the 17th week to the 20th week of gestation.
- Age of participants will range from 20-30 years.
- Their BMI will not exceed 28 kg/m.
Who cannot join
- • Any dermal pathology.
- Psychiatric disorders.
- Skin tumor.
- Pregnant with more than one child.
- History or symptoms of premature birth.
- Placental abruption.
- History of abdominal surgeries.
- History of abdominal hernia.
Trial locations and contacts
1 site in 1 country.
Egypt1 site
Outpatient Clinics, Faculty of Physical Therapy, Kafrelsheikh University, Egypt
Kafr ash Shaykh, Kafr el-Sheikh Governorate, 33511
About this study
Official title: The Efficacy of Effleurage Massage on Striae Gravidarum During Pregnancy
The goal of this clinical trial is to learn if our new specialized technique using effleurage massage works to prevent striae gravidarum in primigravida. The main questions it aims to answer are:
Can our new specialized technique using effleurage massage prevent or even decrease the severity of striae gravidarum in primigravida ? What side effects may participants face when using our technique?
Read more
Participants will:
perform effleurage massage in transverse direction from medial to lateral only not back and forth, twice a day starting from the 17th week until the 28th week of pregnancy and three times a day starting from the 28th week of pregnancy for 10 minutes for each time until date of birth but from lateral to medial. It will be performed on the whole abdominal area extending from the diaphragm to the pupic area, also on both sides of the abdomen extending from the 12th rib to the iliac crest.
Read the detailed description
This study will be conducted to investigate if our new specialized technique using effleurage massage can prevent or even decrease the severity of striae gravidarum in primigravida .
Participants will:
perform effleurage massage in transverse direction from medial to lateral only not back and forth, twice a day starting from the 17th week until the 28th week of pregnancy and three times a day starting from the 28th week of pregnancy for 10 minutes for each time until date of birth but from lateral to medial. It will be performed on the whole abdominal area extending from the diaphragm to the pupic area, also on both sides of the abdomen extending from the 12th rib to the iliac crest.
- Conditions
- Striae Gravidarum
- Being tested
- New specialized technique using effleurage massage
- Medical subject headings
- Striae Distensae
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
New specialized technique using effleurage massageOther
effleurage massage was performed in transverse direction from medial to lateral only not back and forth, twice a day starting from the 17th week until the 28th week of pregnancy and three times a day starting from the 28th week of pregnancy for 10 minutes for each time until date of birth but from lateral to medial. It will be performed on the whole abdominal area extending from the diaphragm to the pupic area, also on both sides of the abdomen extending from the 12th rib to the iliac crest.
| Study group | Role | What they receive |
|---|---|---|
| Efficacy of EM on SG | Active comparator | Each patient in this group will perform effleurage massage in transverse direction from medial to lateral only not back and forth, twice a day starting from the 17th week until the 28th week of pregnancy and three times a day starting from the 28th week of pregnancy for 10 minutes for each time until date of birth but from lateral to medial. It will be performed on the whole abdominal area extending from the diaphragm to the pupic area, also on both sides of the abdomen extending from the 12th rib to the iliac crest. Receives: Other: New specialized technique using effleurage massage |
| Efficacy of olive oil only on SG | Active comparator | They will apply olive oil only twice a day starting from the 17th week until the 28th week of pregnancy and three times a day starting from the 28th week of pregnancy until date of birth . Receives: Other: New specialized technique using effleurage massage |
What is being measured
The primary outcome is the main question the study is designed to answer.
Reduction in Striae Gravidarum severity
Severity of striae gravidarum will be assessed using INA score at three time points during pregnancy to evaluate progression and response to the intervention
Measured: At 21 weeks of gestation, 29 weeks of gestation ,and 39 weeks of gestation
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Dec 2025
- Study start9 Oct 2024
- Primary completion12 Jan 2025
- Study completion30 May 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Striae GravidarumStudies of the same condition, open and under way.
- More trials run by Kafrelsheikh UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 42 participants (actual)
Sponsor and investigators
- Lead sponsor
- Kafrelsheikh University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Eman Khaled Mohamed Fathelbab, Kafrelsheikh University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07265440
- Sponsor's protocol ID
- KFSIRB200-764
- Acronym
- EM/SG
- Status last verified
- Nov 2025
- First submitted
- 22 Nov 2025
- Last updated
- 4 Dec 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data (IPD) will not be shared. This study involves sensitive participant information and there is no plan for data sharing.
Study at a glance
From the registry record, last updated by the sponsor on 4 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Efficacy of Effleurage Massage on Striae Gravidarum During Pregnancy
- ClinicalTrials.gov ID
- NCT07265440
- Acronym / sponsor ID
- EM/SG / KFSIRB200-764
- Conditions
- Striae Gravidarum
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 42 participants (actual)
- Lead sponsor
- Kafrelsheikh UniversityUniversity, hospital or other
- Study start
- 9 Oct 2024 (actual)
- Primary completion
- 12 Jan 2025 (actual)
- Study completion
- 30 May 2025 (actual)
- First posted
- 4 Dec 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to learn if our new specialized technique using effleurage massage works to prevent striae gravidarum in primigravida. The main questions it aims to answer are:
Can our new specialized technique using effleurage massage prevent or even decrease the severity of striae gravidarum in primigravida ? What side effects may participants face when using our technique?
Participants will:
perform effleurage massage in transverse direction from medial to lateral only not back and forth, twice a day starting from the 17th week until the 28th week of pregnancy and three times a day starting from the 28th week of pregnancy for 10 minutes for each time until date of birth but from lateral to medial. It will be performed on the whole abdominal area extending from the diaphragm to the pupic area, also on both sides of the abdomen extending from the 12th rib to the iliac crest.
Detailed description
This study will be conducted to investigate if our new specialized technique using effleurage massage can prevent or even decrease the severity of striae gravidarum in primigravida .
Participants will:
perform effleurage massage in transverse direction from medial to lateral only not back and forth, twice a day starting from the 17th week until the 28th week of pregnancy and three times a day starting from the 28th week of pregnancy for 10 minutes for each time until date of birth but from lateral to medial. It will be performed on the whole abdominal area extending from the diaphragm to the pupic area, also on both sides of the abdomen extending from the 12th rib to the iliac crest.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Efficacy of EM on SG | Active comparator | Other: New specialized technique using effleurage massageEach patient in this group will perform effleurage massage in transverse direction from medial to lateral only not back and forth, twice a day starting from the 17th week until the 28th week of pregnancy and three times a day starting from the 28th week of pregnancy for 10 minutes for each time until date of birth but from lateral to medial. It will be performed on the whole abdominal area extending from the diaphragm to the pupic area, also on both sides of the abdomen extending from the 12th rib to the iliac crest. |
| Efficacy of olive oil only on SG | Active comparator | Other: New specialized technique using effleurage massageThey will apply olive oil only twice a day starting from the 17th week until the 28th week of pregnancy and three times a day starting from the 28th week of pregnancy until date of birth . |
Who may qualify
- Ages
- 20 to 30 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (4 listed)
- • All females will be primigravida.
Key exclusion criteria (8 listed)
- • Any dermal pathology.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| New specialized technique using effleurage massageeffleurage massage was performed in transverse direction from medial to lateral only not back and forth, twice a day starting from the 17th week until the 28th week of pregnancy and three times a day starting from the 28th week of pregnancy for 10 minutes for each time until date of birth but from lateral to medial. It will be performed on the whole abdominal area extending from the diaphragm to the pupic area, also on both sides of the abdomen extending from the 12th rib to the iliac crest. | Other | Efficacy of EM on SG, Efficacy of olive oil only on SG |
Primary outcome
Reduction in Striae Gravidarum severity
Time frame: At 21 weeks of gestation, 29 weeks of gestation ,and 39 weeks of gestation
Severity of striae gravidarum will be assessed using INA score at three time points during pregnancy to evaluate progression and response to the intervention
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Dec 2025.
- Individual participant dataSharing planned: No. Individual participant data (IPD) will not be shared. This study involves sensitive participant information and there is no plan for data sharing.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing New specialized technique using effleurage massage in people with Striae Gravidarum, run by Kafrelsheikh University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 4 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Reduction in Striae Gravidarum severity (time frame: At 21 weeks of gestation, 29 weeks of gestation ,and 39 weeks of gestation). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Dec 2025.